Browse by UCL people
Group by: Type | Date
Number of items: 30.
Article
Caron, Nicholas S;
Byrne, Lauren M;
Lemarie, Fanny L;
Bone, Jeffrey N;
Aly, Amirah E-E;
Ko, Seunghyun;
Anderson, Christine;
... Hayden, Michael R; + view all
(2024)
Elevated plasma and CSF neurofilament light chain concentrations are stabilized in response to mutant huntingtin lowering in the brains of Huntington's disease mice.
Translational Neurodegeneration
, 13
, Article 50. 10.1186/s40035-024-00443-8.
|
 |
|
Gargouri, F;
Messé, A;
Perlbarg, V;
Valabregue, R;
McColgan, P;
Yahia-Cherif, L;
Fernandez-Vidal, S;
... Lehéricy, S; + view all
(2016)
Longitudinal changes in functional connectivity of cortico-basal ganglia networks in manifests and premanifest huntington's disease.
Human Brain Mapping
, 37
(11)
pp. 4112-4128.
10.1002/hbm.23299.
|
|
Gregory, S;
Long, JD;
Klöppel, S;
Razi, A;
Scheller, E;
Minkova, L;
Johnson, EB;
... Track-On investigators; + view all
(2018)
Testing a longitudinal compensation model in premanifest Huntington's disease.
Brain
, 141
(7)
pp. 2156-2166.
10.1093/brain/awy122.
|
 |
|
Lanskey, JH;
McColgan, P;
Schrag, AE;
Acosta-Cabronero, J;
Rees, G;
Morris, HR;
Weil, RS;
(2018)
Can neuroimaging predict dementia in Parkinson’s disease?
Brain : A Journal of Neurology
, 141
(9)
pp. 2545-2560.
10.1093/brain/awy211.
|
|
|
Li, X;
Xie, S;
McColgan, P;
Tabrizi, SJ;
Scahill, R;
Zeng, D;
Wang, Y;
(2018)
Learning Subject-Specific Directed Acyclic Graphs With Mixed Effects Structural Equation Models From Observational Data.
Frontiers in Genetics
, 9
, Article 430. 10.3389/fgene.2018.00430.
|
|
|
McColgan, P;
Helbling, S;
Vaculciakova, L;
Pine, K;
Wagstyl, K;
Attar, FM;
Edwards, L;
... Weiskopf, N; + view all
(2021)
Relating quantitative 7T MRI across cortical depths to cytoarchitectonics, gene expression and connectomics.
HUMAN BRAIN MAPPING
, 42
(15)
pp. 4996-5009.
10.1002/hbm.25595.
|
|
|
McColgan, P;
Gregory, S;
Razi, A;
Seunarine, KK;
Gargouri, F;
Durr, A;
Roos, RA;
... Johnson, H; + view all
(2017)
White matter predicts functional connectivity in premanifest Huntington's disease.
Annals of Clinical and Translational Neurology
, 4
(2)
pp. 106-118.
10.1002/acn3.384.
|
|
|
McColgan, P;
Gregory, S;
Seunarine, KK;
Razi, A;
Papoutsi, M;
Johnson, E;
Durr, A;
... Tabrizi, SJ; + view all
(2017)
Brain regions showing white matter loss in Huntington’s disease are enriched for synaptic and metabolic genes.
Biological Psychiatry
10.1016/j.biopsych.2017.10.019.
(In press).
|
|
|
McColgan, P;
Joubert, J;
Tabrizi, SJ;
Rees, G;
(2020)
The human motor cortex microcircuit: insights for neurodegenerative disease.
Nature Reviews Neuroscience
, 21
pp. 401-415.
10.1038/s41583-020-0315-1.
|
|
McColgan, P;
Seunarine, K;
Gregory, S;
Razi, A;
Papoutsi, M;
Long, J;
Mills, J;
... Track-On HD Investigators; + view all
(2017)
Topological length of white matter connections predicts their rate of atrophy in premanifest Huntington's disease.
JCI Insight
, 2
(8)
, Article e92641. 10.1172/jci.insight.92641.
|
|
McColgan, P;
Seunarine, KK;
Razi, A;
Cole, JH;
Gregory, S;
Durr, A;
Roos, RA;
... Track-HD Investigators, .; + view all
(2015)
Selective vulnerability of Rich Club brain regions is an organizational principle of structural connectivity loss in Huntington's disease.
Brain
, 138
(Pt 11)
pp. 3327-3344.
10.1093/brain/awv259.
|
|
|
McColgan, P;
Tabrizi, SJ;
(2018)
Huntington's disease: a clinical review.
European Journal of Neurology
, 25
(1)
pp. 24-34.
10.1111/ene.13413.
|
|
McColgan, P;
Viegas, S;
Gandhi, S;
Bull, K;
Tudor, R;
Sheikh, F;
Pinney, J;
... Reilly, MM; + view all
(2015)
Oculoleptomeningeal Amyloidosis associated with transthyretin Leu12Pro in an African patient.
J Neurol
, 262
(1)
228 - 234.
10.1007/s00415-014-7594-2.
|
|
|
Moss, DJH;
Poulter, M;
Beck, J;
Hehir, J;
Polke, JM;
Campbell, T;
Adamson, G;
... Tabrizi, SJ; + view all
(2014)
C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies.
Neurology
, 82
(4)
pp. 292-299.
10.1212/WNL.0000000000000061.
|
|
Razi, A;
Seghier, ML;
Zhou, Y;
McColgan, P;
Zeidman, P;
Park, H-J;
Sporns, O;
... Friston, KJ; + view all
(2017)
Large-scale DCMs for resting state fMRI.
Network Neuroscience
, 1
(3)
pp. 222-241.
10.1162/NETN_a_00015.
|
|
Rodrigues, FB;
Byrne, L;
McColgan, P;
Robertson, N;
Tabrizi, SJ;
Leavitt, BR;
Zetterberg, H;
(2016)
Cerebrospinal fluid total tau concentration predicts clinical phenotype in Huntington's disease.
Journal of Neurochemistry
, 139
(1)
pp. 22-25.
10.1111/jnc.13719.
|
|
Rodrigues, FB;
Byrne, LM;
McColgan, P;
Robertson, N;
Tabrizi, SJ;
Zetterberg, H;
Wild, EJ;
(2016)
Cerebrospinal Fluid Inflammatory Biomarkers Reflect Clinical Severity in Huntington's Disease.
PLOS ONE
, 11
(9)
, Article e0163479. 10.1371/journal.pone.0163479.
|
|
Scahill, RI;
Zeun, P;
Osborne-Crowley, K;
Johnson, EB;
Gregory, S;
Parker, C;
Lowe, J;
... Tabrizi, SJ; + view all
(2020)
Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis.
The Lancet Neurology
, 19
(6)
pp. 502-512.
10.1016/S1474-4422(20)30143-5.
|
|
|
Tabrizi, SJ;
McColgan, P;
Gregory, S;
Seunarine, K;
Durr, A;
Raymund, R;
Leavitt, B;
... Rees, G; + view all
(2017)
Structural and Functional Brain Network Correlates of Depressive Symptoms in Premanifest Huntington’s Disease.
Human Brain Mapping
, 38
(6)
pp. 2819-2829.
10.1002/hbm.23527.
|
|
|
Thomas, G;
Zarkali, A;
Ryten, M;
Shmueli, K;
Gil Martinez, A;
Leyland, L;
McColgan, P;
... Weil, R; + view all
(2021)
Regional brain iron and gene expression provide insights into neurodegeneration in Parkinson’s disease.
Brain
, Article awab084. 10.1093/brain/awab084.
(In press).
|
|
|
Weil, R;
Zarkali, A;
McColgan, P;
Leyland, L;
Lees, A;
Rees, G;
(2020)
Fibre-specific white matter reductions in Parkinson’s hallucinations and visual dysfunction.
Neurology
, 94
(14)
e1525-e1538.
10.1212/WNL.0000000000009014.
|
|
|
Weil, RS;
McColgan, P;
Schrag, AE;
Warren, JD;
Crutch, SJ;
Lees, AJ;
Morris, HR;
(2017)
Reply: MRI findings of visual system alterations in Parkinson's disease.
Brain
, 140
(11)
e70.
10.1093/brain/awx245.
|
|
Xie, S;
Li, X;
McColgan, P;
Scahill, RI;
Zeng, D;
Wang, Y;
(2019)
Identifying disease-associated biomarker network features through conditional graphical model.
Biometrics
10.1111/biom.13201.
(In press).
|
|
Zarkali, A;
McColgan, P;
Leyland, L;
Lees, A;
Weil, R;
(2021)
Longitudinal thalamic white and gray matter changes associated with visual hallucinations in Parkinson’s disease.
Journal of Neurology, Neurosurgery and Psychiatry
, 93
pp. 169-179.
10.1136/jnnp-2021-326630.
|
|
Zarkali, A;
McColgan, P;
Leyland, L;
Lees, A;
Weil, R;
(2021)
Visual dysfunction predicts cognitive impairment and white matter degeneration in Parkinson’s disease.
Movement Disorders
(In press).
|
|
Zarkali, A;
McColgan, P;
Leyland, L-A;
Lees, AJ;
Rees, G;
Weil, RS;
(2021)
Organisational and neuromodulatory underpinnings of structural-functional connectivity decoupling in patients with Parkinson's disease.
Communications Biology
, 4
, Article 86. 10.1038/s42003-020-01622-9.
|
|
|
Zarkali, A;
McColgan, P;
Ryten, M;
Reynolds, R;
Leyland, L;
Lees, A;
Rees, G;
(2020)
Differences in network controllability and regional gene expression underlie visual hallucinations in Parkinson’s disease.
Brain: a journal of neurology
, 143
(11)
pp. 3435-3448.
10.1093/brain/awaa270.
|
|
|
Zarkali, A;
McColgan, P;
Ryten, M;
Reynolds, R;
Leyland, L;
Lees, A;
Rees, G;
(2020)
Dementia risk in Parkinson’s disease is associated with
interhemispheric connectivity loss and determined by regional
gene expression.
NeuroImage: Clinical
, 28
, Article 102470. 10.1016/j.nicl.2020.102470.
|
|
Working / discussion paper
|
Zarkali, A;
McColgan, P;
Leyland, L-A;
Lees, AJ;
Weil, RS;
(2020)
Visual dysfunction predicts cognitive impairment and white matter degeneration in Parkinson's disease.
BioRxiv: Cold Spring Harbor, NY, USA.
|
Thesis
|
McColgan, Peter;
(2018)
Structural Brain Network Degeneration and Functional Up-regulation In Huntington’s disease.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
